Notice Number: NOT-AI-20-018

Key Dates
Release Date: December 18, 2019

Issued by

Purpose

The purpose of this Notice is to revise language regarding Funding Restrictions in RFA-AI-19-068 “Immune Tolerance Network (Clinical Trial Required UM1).

Section IV. Application and Submission Information

6. Funding Restrictions

Currently reads:

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

• Awards issued under this FOA will be incrementally funded awards for project periods of seven years. Multi-year funded grants will not be awarded.
• Grants awarded under this FOA will be excluded from automatic carryover all carryover requests must be approved.
• Grants awarded under this FOA will not be provided the authority to automatically extend the final budget period one time for up to 12 months beyond the original expiration date shown in the Notice of Award all extensions, including the first extension, will require approval.
• Progress and financial reporting will be required and reviewed annually.
• All funds must be expended within the approved project period.

Revised to read:

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

• Awards issued under this FOA will be incrementally funded awards for project periods of seven years.
• Grants awarded under this FOA will be excluded from automatic carryover all carryover requests must be approved.
• Grants awarded under this FOA will not be provided the authority to automatically extend the final budget period one time for up to 12 months beyond the original expiration date shown in the Notice of Award all extensions, including the first extension, will require approval.
• Progress and financial reporting will be required and reviewed annually.
• All funds must be expended within the approved project period.

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Tseday Girma
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-747-7388
Email: tseday.girma@nih.gov